Paul Avery

Paul Avery serves as Global CFO at Brainlabs since April 2019, leading financial transformation and growth following a Private Equity investment, which resulted in a successful exit valued at $320 million in 2023. Previously, Paul was Finance Director at Aesica Pharmaceuticals, part of Consort Medical Plc, overseeing finance, IT, and procurement while transitioning the division to a decentralized structure. Additionally, as Group Financial Controller for Consort Medical Plc, Paul managed all group finance matters, including financial reporting and M&A activities. Earlier experience includes a Senior Manager role at Deloitte, providing audit and finance transformation services to multinational clients, and starting as an ACA trainee at Kreston Reeves. Paul holds a 2:1 degree in Biochemistry from the University of Birmingham.